The Human Genome Project was officially completed in 2003 after nearly 15 years of work and at a cost of nearly $3 billion. But now, due to the rapid progression of the technology, we can read an individual’s genome in just 1-2 days for only $1,000 – and it is predicted that this will decrease to $100 in just a few more years! In this new era where individualized DNA analysis will become standard, medical professionals will be able to predict patient risks of future illness. But beyond this very powerful form of preventive medicine, the holy grail of genomic medicine may lay just around the corner. Using the gene editing technology known as CRISPR, researchers at the Brigham are now able to edit human DNA, to improve interpretation of the code and to develop transformative gene-based medicines to treat serious diseases. Panelists participating in this session will discuss genomic sequencing and interpretation, the policies and ethical dilemmas behind providing patients their genetic information and the use of CRISPR technology;